@article{8f9fe4a850fa4958b1298624a8a96d92,
title = "Saved from Sepsis: Can Immunotherapy Improve Acute and Postacute Outcomes?",
keywords = "antiprogrammed cell death ligand-1, immunomodulation, lymphocytopenia, sepsis",
author = "Cawcutt, {Kelly A.} and Kalil, {Andre C.}",
note = "Funding Information: *See also p. 643. Key Words: body mass index; hospital; leptin; mortality; sepsis Dr. Crouser{\textquoteright}s institution received funding from Beckman Coulter, the National Institutes of Health (NIH), and Foundation for Sarcoidosis Research. Dr. Hotchkiss received support for article research from the NIH. Dr. Caldwell disclosed that he does not have any potential conflicts of interest. Copyright {\textcopyright} 2019 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved. DOI: 10.1097/CCM.0000000000003707",
year = "2019",
month = may,
day = "1",
doi = "10.1097/CCM.0000000000003702",
language = "English (US)",
volume = "47",
pages = "733--735",
journal = "Critical care medicine",
issn = "0090-3493",
publisher = "Lippincott Williams and Wilkins",
number = "5",
}